Home › OncoMed moves forward on drug trials halted due to side effects
 

Keywords :   


OncoMed moves forward on drug trials halted due to side effects

2014-09-05 08:39:41| Chemicals - Topix.net

For the second time in a week, the Food and Drug Administration lifted a hold on three early-stage clinical trials of an experimental cancer-fighting drug by OncoMed Pharmaceuticals Inc. The studies are important for Redwood City-based OncoMed because partner Bayer HealthCare has the option under a 2010 deal to an exclusive license of the drugs after the trials are completed. Enrollment in both programs, halted in June , is expected to be under way again soon, OncoMed Chairman and CEO Paul Hastings said late Thursday afternoon.

Tags: due side forward effects

Category:Chemicals

Latest from this category

All news
12.11Benjamin Moore Expands Partnership with Roadie to Accelerate Paint Delivery for DIYers and Pros
11.11Clariant Launches Melamine-free Flame Retardant for Intumescent Coatings
11.11Protech Group Acquires Caldwell Chemical Coatings
11.11Asian Paints Reports 2Q 2024-25 Fiscal Results
10.11Clariant Launches Melamine-free Flame Retardant for Intumescent Coatings
Chemicals »
24.111000 15
24.11 nike soccer usa national team uniform
24.1160266
24.11 1
24.11
24.11GREATEST HITS ALTER EGO EGOIST
24.11(ALINCO)
24.11[]34
More »